Cargando…
Dual Oxidase 2 (DUOX2) as a Proteomic Biomarker for Predicting Treatment Response to Chemoradiation Therapy for Locally Advanced Rectal Cancer: Using High-Throughput Proteomic Analysis and Machine Learning Algorithm
High-throughput mass-spectrometry-based quantitative proteomic analysis was performed using formalin-fixed, paraffin-embedded (FFPE) biopsy samples obtained before treatment from 13 patients with locally advanced rectal cancer (LARC), who were treated with concurrent chemoradiation therapy (CCRT) fo...
Autores principales: | Lee, Hyebin, Ryu, Han Suk, Park, Hee Chul, Yu, Jeong Il, Yoo, Gyu Sang, Choi, Changhoon, Nam, Heerim, Lee, Jason Joon Bock, Do, In-Gu, Han, Dohyun, Ha, Sang Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656829/ https://www.ncbi.nlm.nih.gov/pubmed/36361712 http://dx.doi.org/10.3390/ijms232112923 |
Ejemplares similares
-
High Immunoreactivity of DUOX2 Is Associated With Poor Response to Preoperative Chemoradiation Therapy and Worse Prognosis in Rectal Cancers
por: Lin, Shih-Chun, et al.
Publicado: (2017) -
Digenic DUOX1 and DUOX2 Mutations in Cases With Congenital Hypothyroidism
por: Aycan, Zehra, et al.
Publicado: (2017) -
The application of high-throughput proteomics in cytopathology
por: Nikas, Ilias P., et al.
Publicado: (2022) -
Clinical and molecular characteristics of congenital hypothyroidism with DUOX2 mutations
por: Kim, Yoo-Mi, et al.
Publicado: (2013) -
Reactive Oxygen Species Regulate the Levels of Dual Oxidase (Duox1-2) in Human Neuroblastoma Cells
por: Damiano, Simona, et al.
Publicado: (2012)